InMed Pharmaceuticals Reports Third Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update

VANCOUVER, May 14, 2020 /PRNewswire/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN;OTCQX: IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and …

Vireo Health Announces Fourth Quarter and Fiscal Year 2019 Financial Results and Pre-Announces First Quarter 2020 Revenue

– Fourth-quarter revenue of $9.0 million increased 13% sequentially and 60% year-over-year – – One-time impairment charge of $28.3 million reflects changing market valuations – …

MediPharm Labs Signs Wide-Ranging Strategic Manufacturing and IP Licensing Agreement with Biopharmaceutical Leader Avicanna Inc.

BARRIE, Ontario, May 14, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in …